AAV r3.45
(Plasmid
#233684)
-
PurposeAn evolved Adeno-associated viral variant, enhances gene delivery and gene targeting in neural stem cells
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 233684 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepSub2
- Backbone size w/o insert (bp) 6000
- Total vector size (bp) 8369
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameModified AAV2 Rep, Cap
-
Mutationinsertion of LATQVGQKTA (where LA and A are linker residues) at amino acid 587 with an additional V719M mutation
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
AAV r3.45 was a gift from David Schaffer (Addgene plasmid # 233684 ; http://n2t.net/addgene:233684 ; RRID:Addgene_233684) -
For your References section:
An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells. Jang JH, Koerber JT, Kim JS, Asuri P, Vazin T, Bartel M, Keung A, Kwon I, Park KI, Schaffer DV. Mol Ther. 2011 Apr;19(4):667-75. doi: 10.1038/mt.2010.287. Epub 2011 Jan 11. 10.1038/mt.2010.287 PubMed 21224831